Shared Resource: Biosample Repository Facility

共享资源:生物样本储存库设施

基本信息

项目摘要

MODEL SYSTEMS SHARED RESOURCE: BIOSAMPLE REPOSITORY FACILITY (BRF) PROJECT SUMMARY/ABSTRACT Fox Chase Cancer Center (FCCC) established biospecimen banking activities in 1987 to coordinate the ethical collection, storage, annotation and distribution of tissue and peripheral blood samples to support translational research. This centralized shared resource operates under the supervision of Denise Connolly, PhD (MT) and is advised by an inter-programmatic Facility Advisory Committee (FAC). To enhance BRF services, the Center invested $369,770 for a PE Vectra Multispectral Quantitative Imaging System and a MesoScale Discovery chemiluminescent ELISA platform. The Biosample Repository Facility (BRF) has three major functions: 1) to identify participants, obtain informed consent, collect tissue, blood and/or urine specimens and obtain information on personal and family histories of cancer, clinical intervention and lifestyle factors for use in research; 2) to process and store human biospecimens obtained through investigator-initiated studies; and 3) to provide tissue-related analysis services including custom tissue microarray (TMA) construction, standard immunoperoxidase and fluorescent immunohistochemical detection and analysis of biomarker expression. Working in collaboration with pathologists, medical oncologists, surgeons and other hospital personnel, specifically trained BRF staff obtains subject informed consent, collects samples and assembles comprehensive clinical, pathological and personal/demographic information about each donor and the corresponding samples. As part of this banking process, the BRF staff provides: 1) diagnostic pathology support; 2) a comprehensive informed consent process for the appropriate collection of tissue, blood and other biospecimens for research; 3) a specialized biospecimen bank devoted to the collection and distribution of de- identified specimens to support research; 4) custom TMA construction; 5) immunohistochemical staining; 6) computer assisted tissue analysis services; and 7) extensive supporting data from the clinical record and self- reported health history of each participant. All specimens collected by and housed in the BRF are linked to comprehensive clinical databases supported by the Population Studies Facility (PSF). The BRF currently houses over 16,500 fresh-frozen tissue samples, over 47,000 blood samples, and has access to >100,000 surgical pathology cases. The annual accruals for new tissue and blood specimens are approximately 1,500 and 3,000, respectively. In 2014, the BRF served 31 FCCC investigators (24 peer-review funded) across all five Research Programs. Ninety (90%) percent of the BRF's 2014 use (by primary service line) was by peer-review funded Cancer Center members. Future plans involve the Center's commitment to construct a dedicated freezer farm that will provide sample storage capacity for the next ten years.
模型系统共享资源:生物样品存储库设施(BRF) 项目摘要/摘要 Fox Chase Cancer Center(FCCC)于1987年建立了Biospecimen Banking活动,以协调道德 组织和外周血样本的收集,存储,注释和分布以支持翻译 研究。该集中的共享资源在Denise Connolly,PhD(MT)和 由程序间设施咨询委员会(FAC)建议。为了增强BRF服务,该中心 为PE Vectra多光谱定量成像系统和中尺度发现投资369,770美元 化学发光ELISA平台。生物样品存储库设施(BRF)具有三个主要功能:1) 确定参与者,获得知情同意,收集组织,血液和/或尿液标本并获得 有关癌症的个人和家庭历史,临床干预和生活方式因素的信息 研究; 2)处理和存储通过研究人员发起的研究获得的人类生物测量; 3) 提供与组织相关的分析服务,包括定制组织微阵列(TMA)结构,标准 免疫过氧化物酶和荧光免疫组织化学检测和生物标志物表达的分析。 与病理学家,医学肿瘤学家,外科医生和其他医院人员合作, 经过专门培训的BRF员工获得了知情同意,收集样本和集会 有关每个捐赠者和的全面临床,病理和个人/人口统计信息 相应的样品。作为此银行过程的一部分,BRF员工提供:1)诊断病理 支持; 2)适当收集组织,血液和其他的全面知识同意过程 研究生物测量; 3)专门用于收集和分配的专业生物循环银行 确定了支持研究的标本; 4)定制TMA构造; 5)免疫组织化学染色; 6) 计算机辅助组织分析服务; 7)来自临床记录和自我的广泛支持数据 报告了每个参与者的健康历史。 BRF中收集和安置的所有标本都链接到 人口研究机构(PSF)支持的全面临床数据库。 BRF当前 房屋超过16,500个新鲜的组织样品,超过47,000个血液样本,可以使用> 100,000 外科病理病例。新组织和血液标本的年应计费约为1,500 和3,000。 2014年,BRF为31名FCCC调查人员(由24个同行评审资助)服务于所有人 五个研究计划。 BRF 2014年使用(主要服务线)的90%(90%)是 同行评审资助的癌症中心成员。未来的计划涉及中心建造一个的承诺 专用的冰柜农场将在未来十年内提供样品存储容量。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DENISE C CONNOLLY其他文献

DENISE C CONNOLLY的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DENISE C CONNOLLY', 18)}}的其他基金

Pilot Research Project: Evaluating Black and African American Breast Cancer Populations for Therapeutic Targeting of Aberrant p53, MDM2, MDMX, and PARP signaling
试点研究项目:评估黑人和非裔美国人乳腺癌人群的异常 p53、MDM2、MDMX 和 PARP 信号传导靶向治疗
  • 批准号:
    10757261
  • 财政年份:
    2018
  • 资助金额:
    $ 15.94万
  • 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
  • 批准号:
    8238368
  • 财政年份:
    2009
  • 资助金额:
    $ 15.94万
  • 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
  • 批准号:
    7730607
  • 财政年份:
    2009
  • 资助金额:
    $ 15.94万
  • 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
  • 批准号:
    8052931
  • 财政年份:
    2009
  • 资助金额:
    $ 15.94万
  • 项目类别:
The Role of HEF1 in Ovarian Cancer Development, Progression, and Metastasis
HEF1 在卵巢癌发生、进展和转移中的作用
  • 批准号:
    8460153
  • 财政年份:
    2009
  • 资助金额:
    $ 15.94万
  • 项目类别:
Shared Resource: Biosample Repository Facility
共享资源:生物样本储存库设施
  • 批准号:
    10427539
  • 财政年份:
    1997
  • 资助金额:
    $ 15.94万
  • 项目类别:

相似海外基金

Administrative
行政的
  • 批准号:
    10588960
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
Cancer Research Training and Education Coordination
癌症研究培训和教育协调
  • 批准号:
    10625752
  • 财政年份:
    2023
  • 资助金额:
    $ 15.94万
  • 项目类别:
Center for Solutions for ME/CFS
ME/CFS 解决方案中心
  • 批准号:
    9761452
  • 财政年份:
    2017
  • 资助金额:
    $ 15.94万
  • 项目类别:
Center for Solutions for ME/CFS
ME/CFS 解决方案中心
  • 批准号:
    10246404
  • 财政年份:
    2017
  • 资助金额:
    $ 15.94万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10246405
  • 财政年份:
    2017
  • 资助金额:
    $ 15.94万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了